Reproductive and pregnancy outcomes of fertility-sparing treatments for early-stage endometrial cancer or atypical hyperplasia: A systematic review and meta-analysis
Ginecologia e ObstetríciaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- European journal of obstetrics, gynecology, and reproductive biology
- Publicado em
- 25 abr 2022
- Citações
- 0
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Reproductive and pregnancy outcomes of fertility-sparing treatments for early-stage endometrial cancer or atypical hyperplasia: A systematic review and meta-analysis
Silvia De Rocco, Danilo Buca, Ludovica Oronzii, Marco Petrillo, Francesco Fanfani, Luigi Nappi, Marco Liberati, Francesco D'Antonio, Giovanni Scambia, Martina Leombroni et al.
Descritores MeSH
- Fertility Preservation
- Endometrial Hyperplasia
- Intrauterine Devices, Medicated
- Precancerous Conditions
- Endometrial Neoplasms
- Abortion, Spontaneous
- Levonorgestrel
- Pregnancy
- Pregnancy Outcome
- Female
Veja também
Estudos relacionados
- Fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer
- A multi-centre randomised controlled trial comparing megestrol acetate to levonorgestrel-intrauterine system in fertility sparing treatment of atypical endometrial hyperplasia
- Fertility and obstetric outcomes after fertility-sparing treatment for early-stage endometrial cancer and atypical hyperplasia: a systematic review and meta-analysis
- Fertility-preserving treatment for stage IA endometrial cancer: a systematic review and meta-analysis